[Infant mortality due to birth defects in the Czech Republic in 1994-2004]

A Sípek1, V Gregor, J Horácek

  • 1Ustav pro péci o matku a dítĕ, Praha.

Ceska Gynekologie
|November 30, 2006
PubMed

Insights

This study analyzed birth defects in the Czech Republic from 1994-2004, finding they significantly contribute to infant mortality. Improved prenatal diagnostics and neonatal care are crucial for better infant survival rates.

Area of Science:

  • Medical Genetics
  • Public Health
  • Pediatrics

Context:

  • Birth defects pose a significant challenge to infant health and survival.
  • Understanding the epidemiology of congenital anomalies is vital for public health initiatives.
  • The Czech Republic provides a valuable dataset for studying birth defect trends.

Purpose:

  • To analyze the occurrence of selected birth defects in the Czech Republic between 1994 and 2004.
  • To evaluate the infant mortality rate associated with these congenital anomalies.
  • To assess the impact of prenatal diagnostics and secondary prevention strategies.

Summary:

  • A retrospective analysis of over one million births revealed incidences of various birth defects, including neural tube defects, abdominal wall defects, and Down syndrome.
  • Secondary prevention rates were high for neural tube defects (61-100%) and Down syndrome (63%).
  • First-year survival rates varied, with congenital hydrocephalus and neural tube defects showing lower survival (63% and 82% respectively), while other operable defects had 76-91% survival.

Impact:

  • Birth defects are a major contributor to infant mortality and morbidity.
  • Prematurity combined with birth defects worsens infant prognosis and healthcare needs.
  • Enhancing prenatal diagnostics and neonatal intensive care can improve survival outcomes for infants with congenital anomalies.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Probability Laws01:49

Probability Laws

Overview
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...